Pluri (PLUR) Non Operating Income (2012 - 2025)
Pluri (PLUR) posted quarterly Non Operating Income of -$374000.0 for Q4 2025, down 120.25% year-over-year from $1.8 million in Q4 2024, and down 278.1% quarter-over-quarter from $210000.0 in Q3 2025.
Pluri (PLUR) Non Operating Income (2012 - 2025) Analysis & Trends
Pluri (PLUR) has reported Non Operating Income for 13 consecutive years, with -$374000.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Non Operating Income fell 120.25% year-over-year to -$374000.0; the TTM figure through Dec 2025 stood at -$2.3 million (down 269.96% YoY), while the FY2025 annual figure was -$1.1 million, down 232.56% from the prior year.
- Non Operating Income slipped to -$374000.0 in Q4 2025 per PLUR's latest filing, from $210000.0 in the prior quarter.
- Across five years, Non Operating Income topped out at $1.8 million in Q4 2024 and bottomed at -$1.6 million in Q4 2022.
- Historically, Non Operating Income has averaged -$147857.1 across 4 years, with a median of $41000.0 in 2023.
- Annual changes were most pronounced in 2024 — Non Operating Income soared 743.38% — and 2025, when it plunged 770.35%.
- Pluri's Non Operating Income stood at -$1.6 million in 2022, then surged by 113.9% to $219000.0 in 2023, then jumped by 743.38% to $1.8 million in 2024, then plunged by 120.25% to -$374000.0 in 2025.
- Business Quant data shows PLUR's Non Operating Income at -$374000.0 in Q4 2025, $210000.0 in Q3 2025, and -$1.2 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 234.30 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -53.64 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | -51.63 Mn |
| 10 | Pluri | 16.21 Mn | 3.72 Mn | 86,000.00 | -374,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -374,000.00 |
| Sep 30, 2025 | 210,000.00 |
| Jun 30, 2025 | -1.15 Mn |
| Mar 31, 2025 | -935,000.00 |
| Dec 31, 2024 | 1.85 Mn |
| Sep 30, 2024 | -838,000.00 |
| Jun 30, 2024 | 172,000.00 |
| Mar 31, 2024 | 144,000.00 |
| Dec 31, 2023 | 219,000.00 |
| Sep 30, 2023 | 279,000.00 |
| Jun 30, 2023 | -62,000.00 |
| Mar 31, 2023 | -658,000.00 |
| Dec 31, 2022 | -1.58 Mn |
| Sep 30, 2022 | 654,000.00 |
| Jun 30, 2020 | 378,000.00 |
| Mar 31, 2020 | -108,000.00 |
| Dec 31, 2019 | -2,000.00 |
| Sep 30, 2019 | 56,000.00 |
| Jun 30, 2019 | 171,000.00 |
| Mar 31, 2019 | 222,000.00 |